As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value.
Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.
This report shines a spotlight on:
- What’s driving the increased need for wound care.
- The potential effects of high-cost prescription wound dressings on patients and plan sponsors.
- How Optum Rx helps improve the quality of care while lowering costs.
Related healthcare insights
Thought leaders discuss the intentional vigilance needed to overcome obstacles impeding better access to healthcare for all.
Learn from Optum Rx thought leaders how access, affordability and transparency have become imperatives for pharmacy benefit management.
E-book
This is your employer guide to reducing your healthcare spending.